Akari Therapeutics Plc (AKTX)
11.47
+0.63
(+5.81%)
USD |
NASDAQ |
Sep 04, 16:00
11.63
+0.16
(+1.39%)
After-Hours: 20:00
Akari Therapeutics SG&A Expense (TTM) : 8.796M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.796M |
| March 31, 2026 | 8.747M |
| December 31, 2025 | 9.294M |
| September 30, 2025 | 10.20M |
| June 30, 2025 | 9.95M |
| March 31, 2025 | 9.71M |
| December 31, 2024 | 10.71M |
| September 30, 2024 | 10.52M |
| June 30, 2024 | 11.78M |
| March 31, 2024 | 12.64M |
| March 31, 2023 | 10.95M |
| June 30, 2022 | 9.984M |
| March 31, 2022 | 9.166M |
| December 31, 2021 | 8.081M |
| September 30, 2021 | 8.295M |
| June 30, 2021 | 8.241M |
| March 31, 2021 | 8.985M |
| December 31, 2020 | 9.161M |
| September 30, 2020 | 9.050M |
| June 30, 2020 | 8.565M |
| March 31, 2020 | 8.112M |
| December 31, 2019 | 8.224M |
| Date | Value |
|---|---|
| September 30, 2019 | 8.469M |
| June 30, 2019 | 9.497M |
| March 31, 2019 | 9.917M |
| December 31, 2018 | 10.91M |
| September 30, 2018 | 12.20M |
| June 30, 2018 | 11.98M |
| March 31, 2018 | 12.69M |
| December 31, 2017 | 11.67M |
| September 30, 2017 | 11.01M |
| June 30, 2017 | 11.08M |
| March 31, 2017 | 9.592M |
| December 31, 2016 | 9.544M |
| September 30, 2016 | 8.88M |
| June 30, 2016 | 9.389M |
| March 31, 2016 | 8.590M |
| December 31, 2015 | 7.099M |
| September 30, 2015 | 5.833M |
| June 30, 2015 | 3.505M |
| March 31, 2015 | 2.228M |
| December 31, 2013 | 1.486M |
| September 30, 2013 | 0.4089M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| DBV Technologies SA | 56.62M |
| Cellectis SA | 21.32M |
| argenx SE | 1.537B |
| Autolus Therapeutics Plc | 152.92M |
| Evaxion AS | 4.527M |